Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
10.1016/j.ijantimicag.2009.04.007
Saved in:
Main Authors: | Donaldson, A.D., Razak, L., Liang, L.J., Fisher, D.A., Tambyah, P.A. |
---|---|
Other Authors: | STATISTICS & APPLIED PROBABILITY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/105045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
by: Donaldson, A.D., et al.
Published: (2011) -
HEALTHCARE-ASSOCIATED INFECTIONS IN SINGAPORE WITH A FOCUS ON INFECTIONS CAUSED BY CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA
by: CAI YIYING
Published: (2020) -
Multiresistant Gram-negative infections: A global perspective
by: Ho, J., et al.
Published: (2016) -
Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
by: Lim, T.-P., et al.
Published: (2021) -
Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant enterobacteriaceae and carbapenemase-producing enterobacteriaceae
by: Marimuthu, Kalisvar, et al.
Published: (2020)